Key result
Review details PAR differences between mouse and human platelets to improve translational research models.
Why the study?
Animal models of platelet protease-activated receptor physiology rely heavily on genetically modified mouse strains, which provide insight but possess inherent limitations.
This review highlights critical species differences in platelet protease-activated receptors between mice and humans, which is important for translating preclinical thrombosis research.
Answers are grounded in this paper and cite their sources.
Species differences in platelet PARs warrant caution translating mouse thrombosis models to humans; leaves open refined humanized tools for future research.
Protease-activated receptors (PARs) are a class of integral membrane proteins that are cleaved by a variety of proteases, most notably thrombin, to reveal a tethered ligand and promote activation. PARs are critical mediators of platelet function in hemostasis and thrombosis, and therefore are attractive targets for anti-platelet therapies. Animal models studying platelet PAR physiology have relied heavily on genetically modified mouse strains, which have provided ample insight but have some inherent limitations. The current review aims to summarize the notable PAR expression and functional differences between the mouse and human, in addition to highlighting some recently developed tools to further study human physiology in mouse models.
No takes yet. Share an insight, caveat, or question.
Renna et al. (2023) conducted a review in Platelet function in hemostasis and thrombosis. Protease-activated receptors (PARs) was evaluated. This review summarizes notable protease-activated receptor expression and functional differences between mouse and human platelets, highlighting tools to study human physiology in mouse models.
Synapse has enriched 10 related papers. Consider them for comparative context: